Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach

Summary

Background The link between DNA methylation, obesity, and adiposity-related diseases in the general population remains uncertain. Methods and Findings We conducted an association study of body mass index (BMI) and differential methylation for over 400,000 CpGs assayed by microarray in whole-blood-derived DNA from 3,743 participants in the Framingham Heart Study and the Lothian Birth Cohorts, with independent replication in three external cohorts of 4,055 participants. We examined variations in whole blood gene expression and conducted Mendelian randomization analyses to investigate the functional and clinical relevance of the findings. We identified novel and previously reported BMI-related differential methylation at 83 CpGs that replicated across cohorts; BMI-related differential methylation was associated with concurrent changes in the expression of genes in lipid metabolism pathways. Genetic instrumental variable analysis of alterations in methylation at one of the 83 replicated CpGs, cg11024682 (intronic to sterol regulatory element binding transcription factor 1 [SREBF1]), demonstrated links to BMI, adiposity-related traits, and coronary artery disease. Independent genetic instruments for expression of SREBF1 supported the findings linking methylation to adiposity and cardiometabolic disease. Methylation at a substantial proportion (16 of 83) of the identified loci was found to be secondary to differences in BMI. However, the cross-sectional nature of the data limits definitive causal determination. Conclusions We present robust associations of BMI with differential DNA methylation at numerous loci in blood cells. BMI-related DNA methylation and gene expression provide mechanistic insights into the relationship between DNA methylation, obesity, and adiposity-related diseases.

Related articles

• Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)

  This study assesses the efficacy of preoperative short-term radiotherapy followed by chemotherapy compared to standard long-term chemoradiotherapy in patients with locally advanced rectal cancer, evaluating outcomes such as disease-free survival and treatment toxicity.

• Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis

  This document discusses the adoption of the kappa free light chain (KFLC) index as a diagnostic tool for multiple sclerosis (MS), detailing its role alongside MRI and expert assessments to enhance diagnostic accuracy and reduce latency.

• Diagnostic Performance of Red Blood Cell Indices in the Differential Diagnosis of Iron Deficiency Anemia and the Thalassemia Trait in Chile: A Retrospective Study

  This retrospective study evaluates the diagnostic performance of 29 red blood cell indices in differentiating between iron deficiency anemia and the thalassemia trait in Chile, analyzing CBC results from 182 patients.

• MRI to guide clinical management of rectal cancer: updated consensus recommendations from the European Society of Gastrointestinal and Abdominal Radiology (ESGAR): PART II-Restaging and response evaluation

  This document presents updated consensus recommendations for the use of MRI in the restaging and response evaluation of rectal cancer after neoadjuvant treatment, developed by a panel of experts from the European Society of Gastrointestinal and Abdominal Radiology (ESGAR).

• NURSING BULLETS FUNDAMENTALS OF NURSING

  This document serves as a comprehensive guide for nursing fundamentals, covering essential topics and clinical practices for nurses, including patient safety, medication administration, and nursing processes.